Mohammed Saad, Osama Risha, Makoto Sano, Thomas Fink, Christian-Hendrik Heeger, Julia Vogler, Vanessa Sciacca, Charlotte Eitel, Thomas Stiermaier, Alexander Joost, Ahmad Keelani, Georg Fuernau, Roza Meyer-Saraei, Karl-Heinz Kuck, Ingo Eitel, Roland Richard Tilz
Background: Data reporting a head-to-head comparison between Amulet and Watchman devices are scarce. The aim of this study was to compare the Watchman™ versus Amulet™ left atrial appendage closure (LAAC) devices in a consecutive, industry-independent registry. Methods: Patients who underwent LAAC using Watchman or Amulet devices from January 2014 to December 2019 at the University Heart Center Lübeck, Lübeck, Germany were included in the present analysis. Primary endpoints included periprocedural complications (in-hospital death, pericardial tamponade, device embolization, stroke, major bleeding and vascular access complications), and complications during long-term follow-up (ischemic stroke, hemorrhagic stroke, thromboembolism, device thrombus, bleeding and death)...
December 2021: IJC Heart & Vasculature